6533b7d4fe1ef96bd1261e23
RESEARCH PRODUCT
Methodological matters on an Alzheimer's dementia trial: is a double-blind randomized controlled study design sufficient to draw strong conclusions on treatment? Reply to Dr Mazza and colleagues.
Luigi CalvoRosario ScaglioneG. LicataSalvatore Corraosubject
medicine.medical_specialtybusiness.industryGinkgo bilobamedicine.diseaselaw.inventionDouble blindNeurologyRandomized controlled trialDouble-Blind MethodPiperidineslawAlzheimer DiseaseIndansmedicineDementiaHumansAlzheimer s dementiaDementiaDonepezilNeurology (clinical)Cholinesterase InhibitorsPsychiatrybusinessRandomized Controlled Trials as Topicyear | journal | country | edition | language |
---|---|---|---|---|
2007-08-28 | European journal of neurology |